US 2010/0063070 A1Published application

Combination for use in the treatment of inflammatory disorders

OwnerJohan Raudinventor

Life of this patent

Estimating the term…

Abstract

There is provided combination products comprising (a) pemirolast, or a pharmaceutically-acceptable salt or solvate thereof; and (b) a statin, or a pharmaceutically-acceptable salt or solvate thereof. Such combination products find particular utility in the treatment of atheresclerosis and related conditions.

Claims21

Dependent claims

A combination product comprising:

(a) pemirolast, or a pharmaceutically-acceptable salt or solvate thereof;
and
(b) a statin, or a pharmaceutically-acceptable salt or solvate thereof.

Dependencies are inferred from the claim text.

Facts

Application: 12/448,326Filed 16 Dec 2007
Priority: 18 Dec 2006
Published: 11 Mar 2010
Term ends: Not estimatedThe source records don’t support an estimate.

Classification23 codes

A61K 31/505
Having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines: pyrimidines; Hydrogenated…
A61K 31/22
Of carboxylic acids: of acyclic acids, e.g. pravastatin
A61K 31/366
Lactones: having six-membered rings, e.g. delta-lactones
A61K 31/40
Having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins: having five-membered rings with one nitrogen as the only ring hetero atom,…

Family

Application60/875,377Us provisional application · filed 18 Dec 2006
Application61/000,743Us provisional application · filed 29 Oct 2007
US 2010/0063070 A1This patent

From the US filing history. Foreign family members aren’t listed.

Timeline

Citations

Open elsewhere

patentgrep

Loading patent…

patentgrepSearch patents

Back to results